The Qiara range of products is a single strain probiotic isolated from human breastmilk, containing Lactobacillus Fermentum CECT5716. Qiara is currently available in the following dosages:
Clinical trials have shown that the probiotic, Lactobacillus Fermentum CECT5716, is effective in the treatment of breast pain and mastitis as well as confer health benefits to infants by out-competing pathogenic bacteria for resources in a patient's microbiome.
Clinical trials have shown that Lactobacillus Fermentum CECT5716 (Qiara) :
Clinical trials with infants has shown that taking Lactobacillus Fermentum CECT5716 (Qiara) resulted in a reduction of 46-71% in incidence of gastrointestinal infections (1-12 months of age) and 27% reduction in respiratory infections (6-12 months of age).
Studies also show that mothers who undergo c-sections were more likely to be diagnosed with a complication affecting breastfeeding and their infants were more likely to be hospitalised with GI infections or bronchiolitis. This may be due to the fact that c-section and GBS positive mothers are routinely treated with antibiotics which indiscriminately kill probiotic as well as pathogenic bacteria in the body.
Supplementation with QIara can assist in restoring the microbiome balance in these cases.
Antibiotics treatments indiscriminately kill probiotic as well as pathogenic bacteria in the body, potentially causing an imbalance in the patient's microbiome. Supplementation with Qiara to restore a patient's probiotic levels can help improve the health of both mother and baby.
Patients are recommended to take Qiara at least 2 hours apart from their antibiotic treatment.
The difference between results and promises is research. Qiara is a single strain probiotic with clinical trials demonstrating its efficacy.
It is important to select the right probiotic strain researched for and suited to your needs. Like other living organisms, probiotics are classified by genus, species and strain (usually a collection of numbers/letters, eg. Lactobacillus Fermentum CECT5716). For example, all breeds of dogs belong to the genus and species canis familiaris, but different breeds of dogs have different characteristics and skills. You wouldn't use a chihuahua as a guard dog or a St Bernard as a sheep dog. Likewise, different probiotic strains have different roles in the body. You need to ensure that you select the right strain of probiotic suited to and researched for your specific needs.
Clinical trials for probiotics are usually conducted with a single strain. Many companies choose to provide “broad spectrum” probiotics products that combine multiple strains with multiple product efficacy claims. However, unless clinical trials have been conducted on the use of these specific combinations of multiple strains in a single dose, it is not possible to determine how these strains interact or inhibit each other and what efficacy they provide.
Containing only a single strain probiotic, Lactobacillus Fermentum CECT5716, Qiara has been heavily researched, and its use and expected outcomes are supported by specific clinical trials.
